Literature DB >> 23117385

Early albumin use improves mortality in difficult to resuscitate burn patients.

Sandra H Park1, Mark R Hemmila, Wendy L Wahl.   

Abstract

BACKGROUND: The optimal resuscitation algorithm remains elusive for patients with a large burn injury. Recent reports from the military support that larger burns that do not respond well to ongoing lactated Ringer's solution resuscitation may improve with the use of 5% albumin and vasopressors. We hypothesized that the use of 5% albumin and vasopressors, as needed, would decrease complications of fluid resuscitation and burn mortality.
METHODS: Fluid needs during the first 24 hours after burn injury, complications, and demographics were collected from all patients 12 years and older with burn size 20% or more of total body surface area admitted from 2003 to 2010. In March 2007, we changed our resuscitation to include the use of 5% albumin in the first 24 hours if the estimated fluid needs at 12 hours after burn would lead to a fluid volume of 6 mL/kg per percent burn at 24 hours. The patients treated before this change (Preprotocol) were compared with those treated after the guideline change (Postprotocol).
RESULTS: The two groups were well matched for age, burn size, and inhalation injury. Ventilator days and mortality were decreased in the Postprotocol group. There was a trend toward less intravenous fluid use in the Postprotocol group where the use of albumin was higher. There was significantly less vasopressor infusion in the Postprotocol group. There was no statistical difference in the number of escharotomies performed or overall incidence of abdominal compartment syndrome, but no patient required open laparotomy in the Postprotocol group.
CONCLUSION: An algorithm incorporating albumin use in the first 24 hours after burn injury was associated with the use of less vasopressor agents and lower mortality. Early albumin use was also associated with a shorter duration of mechanical ventilation in burn patients sustaining burns 20% or more total body surface area. LEVEL OF EVIDENCE: Therapeutic study, level IV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117385     DOI: 10.1097/TA.0b013e31827019b1

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  4 in total

1.  Cardiovascular Responsiveness to Vasopressin and α1-Adrenergic Receptor Agonists After Burn Injury.

Authors:  Ann E Evans; P Geoff Vana; Heather M LaPorte; Richard H Kennedy; Richard L Gamelli; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2017 Mar/Apr       Impact factor: 1.845

2.  Rhabdomyolysis, compartment syndrome and thermal injury.

Authors:  Yusuf Kenan Coban
Journal:  World J Crit Care Med       Date:  2014-02-04

3.  Burn Resuscitation Practices in North America: Results of the Acute Burn ResUscitation Multicenter Prospective Trial (ABRUPT).

Authors:  David G Greenhalgh; Robert Cartotto; Sandra L Taylor; Jeffrey R Fine; Giavonni M Lewis; David J Smith; Michael A Marano; Angela Gibson; Lucy A Wibbenmeyer; James H Holmes; Julie A Rizzo; Kevin N Foster; Anjay Khandelwal; Sarah Fischer; Mark R Hemmila; David Hill; Ariel M Aballay; Edward E Tredget; Jeremy Goverman; Herbert Phelan; Carlos J Jimenez; Anthony Baldea; Rajiv Sood
Journal:  Ann Surg       Date:  2021-08-19       Impact factor: 12.969

4.  Albumin in Burn Shock Resuscitation: A Meta-Analysis of Controlled Clinical Studies.

Authors:  Roberta J Navickis; David G Greenhalgh; Mahlon M Wilkes
Journal:  J Burn Care Res       Date:  2016 May-Jun       Impact factor: 1.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.